Circulating visfatin levels in the second and third trimester of pregnancies with gestational diabetes: a systematic review

Pace, Nikolai Paul; Bonello, Antonia; Roshan, Mohsin H. K; Vassallo, Josanne

doi:10.23736/s0026-4784.18.04293-4

Cited by 4 publications

(1 citation statement)

References 88 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Inflammatory mediators, which are secreted from adipose tissue and placenta in the third trimester, can lead to inflammation during pregnancy (35,36). Moreover, inflammatory cytokines have been reported to have role in the pathogenesis of IR (37,38). The present study found no correlation between RBCs and IR.…”

Section: Discussioncontrasting

confidence: 68%

Association between insulin resistance and haematological parameters in pregnant women: A cross‑sectional study

et al. 2021

View full text Add to dashboard Cite

Limited research has been conducted on the association between insulin resistance (IR) and haematological parameters, such as red cell distribution width, white blood cell count and mean platelet volume. To date, at least to the best of our knowledge, there are no published data available on IR and haematological parameters during pregnancy. In the present study, pregnant women were initially screened for gestational diabetes. Glucose tolerance tests and fasting plasma insulin (FPI) measurements were conducted between 24-28 weeks of gestational age. Homeostatic model assessment of insulin resistance (HOMA-IR), HOMA-β indices and quantitative insulin sensitivity check index (QUICKI) were determined and used to assess insulin sensitivity and β-cell function. A total of 105 non-diabetic pregnant women were included in the present analysis. The mean (± standard deviation) age, parity and gestational age were 28.3 (±5.6) years, 0.9 (±1.2) and 27.1 (±5.2) weeks, respectively. While there was a positive correlation between platelet count and HOMA-IR (r=0.251, P=0.009), there was no correlation between platelet count and the HOMA-β level in the pregnant women examined (n=105). No significant difference was observed in the haematological variables between women with IR (n=17) and women who did not display IR (n=88). On the whole, the present study demonstrates that platelet count is positively associated with IR. This indicates that haematological parameters may help identify pregnant women with IR. However, Further analyses are required in order to fully understand this association.

show abstract

Section: Discussioncontrasting

confidence: 68%

Association between insulin resistance and haematological parameters in pregnant women: A cross‑sectional study

et al. 2021

View full text Add to dashboard Cite

show abstract

The use of biomarkers at the end of the second trimester to predict Gestational Diabetes Mellitus

O’Malley

Reynolds

Killalea

et al. 2020

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

Current Resources for Evidence-Based Practice, May 2020

Bovbjerg¹

2020

Journal of Obstetric, Gynecologic & Neonatal Nursing

View full text Add to dashboard Cite

An extensive review of new resources to support the provision of evidence-based care for women and infants. The current column includes a discussion of a new National Academy of Medicine report on planned place of birth and implications during the SARS-CoV-2 pandemic and commentaries on reviews focused on anorectal sexually transmitted infections and feeding methods following cleft lip repair in infants.

show abstract

Circulating visfatin levels in the second and third trimester of pregnancies with gestational diabetes: a systematic review

Cited by 4 publications

References 88 publications

Association between insulin resistance and haematological parameters in pregnant women: A cross‑sectional study

Association between insulin resistance and haematological parameters in pregnant women: A cross‑sectional study

The use of biomarkers at the end of the second trimester to predict Gestational Diabetes Mellitus

Current Resources for Evidence-Based Practice, May 2020

Contact Info

Product

Resources

About